Since 1987, our HIV Center Grand Rounds have been engaging scientists, clinicians, community members and leaders in diffusing findings from HIV programming in the US and abroad. In our cutting-edge Grand Rounds, we invite some of the world’s leading experts on HIV prevention, care, and treatment to provide insights into their exciting studies. Podcast recordings of the sessions can be found below.
We encourage you to look through the podcasts and also to subscribe to our HIV Center YouTube Channel.
2019 Grand Rounds
VULNERABILITY TO HIV AMONG PEOPLE WHO USE DRUGS IN KENTUCKY: THE RURAL RISK ENVIRONMENT
Hannah Cooper, ScD
Rollins School of Public Health, Emory University
Dr. Cooper holds the Rollins Chair in Substance Use Disorders at Emory University’s Rollins School of Public Health, where she serves as the Co-Director of the Emory Center for AIDS Research’s Prevention Science Core and as Vice Chair of the Department of Behavioral Sciences and Health Education.
TRAUMATIC STRESS AND HIV: IMPLICATIONS FOR PREVENTION AND SCIENCE
Cheryle Gore-Felton, PhD
Stanford University, Department of Psychiatry
Dr. Gore-Felton is Professor of Psychiatry and Behavioral Sciences (Public Mental Health And Population Sciences). She is Associate Chair of the Department of Psychiatry and Behavioral Sciences, and Associate Dean, Academic Affairs, Stanford University School of Medicine.
HOW STIGMA TOWARDS ANAL SEXUALITY IMPEDES ENGAGEMENT IN HIV PREVENTION PRACTICES AMONG US MEN WHO HAVE SEX WITH MEN
Bryan Kutner, PhD, MPH
HIV Center for Clinical and Behavioral Studies, Columbia University
TAKING THE GUESSING OUT OF SEROGUESSING: hIV SELF-TESTING FOR MSM IN CHINA
Chongyi Wei, PhD
Rutgers University School of Public Health
2018 Grand Rounds
INTERSECTIONAL STIGMA AND HIV-RELATED HEALTH: CHALLENGES AND OPPORTUNITIES FOR ASSESSMENT AND PROGRAM
Janet M. Turan, MPH, PhD
University of Alabama at Birmingham, School of Public Health
Dr. Turan is a Professor in the Department of Health Care Organization and Policy at UAB. Her main research interests are in maternal and child health, and HIV prevention in low-resource settings of both developing and developed countries.
MHEALTH FOR DEVELOPMENTALLY TAILORED HIV PREVENTION AND CARE TO YOUNG MEN WHO HAVE SEX WITH MEN
Jose Bauermeister, MPH, PhD
University of Pennsylvania, School of Nursing
Dr. Bauermeister is the 10th Penn Presidential Professor at the University of Pennsylvania. He directs the Scientific Working Group in the Use of Technology to Address HIV Disparities for the Penn Center for AIDS Research, as well as directs the Penn Program on Sexuality, Technology and Action Research (PSTAR) at the School of Nursing.
HIV IN YOUNG WOMEN IN AFRICA: INSIGHTS FROM 30 YEARS OF RESEARCH
Salim S. Abdool Karim, MBChB, PhD, DSc(hc)
Centre for the AIDS Program of Research in South Africa and Mailman School of Public Health, Columbia University
Salim S. Abdool Karim is widely recognized for his research contributions in HIV prevention and treatment. His contributions to microbicides for HIV prevention spans two decades, culminating in the CAPRISA 004 tenofovir gel trial which provided proof-of-concept that antiretroviral drugs can prevent sexually transmitted HIV infection and HSV-2 in women.
PRIMARY, STEADY, AND CASUAL SEX PARTNERS: DIVERSE SOURCES OF SOCIAL SUPPORT WITHIN MSM’S SEXUAL NETWORKS
Jorge Soler, PhD
HIV Center for Clinical and Behavioral Studies
SEXUAL RISK AND HEALTH LITERACY AMONG WOMEN WHO HAVE SEX WITH WOMEN IN THE U.S. AND SOUTHERN AFRICA
Margaret Paschen-Wolff, DrPH
HIV Center for Clinical and Behavioral Studies
THE IMPACT OF DEPRESSION ON HIV TREATMENT OUTCOMES: ACHIEVING 90-90-90
Bryan W. Pence, PhD
University of North Carolina at Chapel Hill
Dr. Wells is an Associate Professor of Epidemiology in behavioral and infectious diseases. He is an expert in behavioral HIV research and has published widely on the influence of depression, stress, traumatic experiences and other mental health conditions on HIV-related behavioral and clinical outcomes in the US and Africa.
PRE-EXPOSURE PROPHYLAXIS FOR WOMEN: AWARENESS, UPTAKE AND IMPLEMENTATION
Oni Blackstock, MD, MHS
New York City Department of Health and Mental Hygiene
Dr. Blackstock is the Assistant Commissioner for the Bureau of HIV/AIDS Prevention and Control for the NYC Health Department. She is also a primary care physician, HIV specialist and researcher. Her prior research has included developing and testing interventions to improve engagement in HIV treatment and prevention services. She has an interest in community-engaged research and advocacy and has been funded by the NIH, NYS Department of Health, and the Centers for Disease Control and prevention.
TRIALS AND TRIBULATIONS: STAKEHOLDER ENGAGEMENT TO SUPPORT BIOMEDICAL HIV PREVENTION TRIALS IN CHINA
Katherine Meyers, DrPH
Aaron Diamond AIDS Research Center, Rockefeller University
SEXUAL STIGMA AS A SOCIAL DETERMINANT OF HIV AND STIs
New York City Department of Health and Mental Hygiene
MOBILE TECHNOLOGY, SEXUALITY, aND THE FUTURE OF RISK BEHAVIORS IN NYC MSM
Erick Schrimshaw, PhD
Department of Sociomedical Sciences, Columbia University Medical Center
Dr. Schrimshaw is a social/health psychologist and associate professor of sociomedical sciences at Columbia University Medical Center. His research over the past 20 years has been in the area of LGB health, with a particular emphasis on HIV risk behaviors of MSM populations. In particular, he has an interest in the role of technology in changing how MSM meet and communicate with potential sexual partners and how this may contribute to sexual risk behaviors among MSM.
HIV AND MENTAL HEALTH: THE REALITY, THE CHALLENGES AND PROMISING SOLUTIONS
Robert H. Remien, PhD
HIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute
Dr. Remien is a Professor of Clinical Psychology and Director of the HIV Center. He has been involved in HIV advocacy, clinical and community work since the early 1980's and has developed a large and diverse portfolio of domestic and international research projects focused on the intersection of HIV prevention and care.
THE CRITICAL ROLE OF BEHAVIORAL RESEARCH IN BIOMEDICAL HIV PREVENTION
Jeffrey T. Parsons, PhD
Hunter College and the Graduate Center of the City University of New York, and the Center for HIV Educational Studies and Training.
Dr. Parsons is a distinguished Professor of Psychology at Hunter College and the Graduate Center and Director of CHEST. His work has shed light on health behaviors, HIV medication adherence, sexual behavior and substance use.
2017 Grand Rounds
INTERVENTIONS TO ADDRESS THE VICIOUS CYCLE OF FOOD INSECURITY AND HIV/AIDS
Sheri Weiser, MD, MPH, MA
School of Medicine and Center for AIDS Prevention Studies, University of California, San Francisco
Dr. Weiser is an internist and Associate Professor of
Medicine at UCSF. Her research focuses on the impact of food insecurity and other structural factors on HIV prevention and treatment outcomes, with a particular focus on food security interventions to improve HIV health outcomes both in the US and in sub-Saharan Africa.
CLOSING THE GAPS IN THE HIV CARE CONTINUUM IN THE US: LOW-HANGING FRUIT OUTSIDE THE BOX AND OTHER MIXED METAPHORS
Thomas Giordano, MD, MPH
Baylor College of Medicine
Dr. Giordano is an Associate Professor of Medicine and Investigator, at the Michael E. DeBakey VA Medical Center, in Houston, TX. He has been involved in HIV clinical care and research since 2000 and Medical Director of the Thomas Street Health Center. He focuses on improving the HIV care continuum, including retention in HIV care.
MEETING THE CHALLENGES IN THE US SOUTH: ENDING HIV IN ALABAMA THROUGH UAB CFAR, COMMUNITY AND CONSUMER COLLABORATION
Michael Mugavero, MD, MHSc
UAB Center for AIDS Research at the University of Alabama at Birmingham
Michael Mugavero, MD, MHSc is a Professor of Medicine with Tenure at the UAB at Birmingham, Co-director of the UAB CFAR and HIV Care provider at the UAB 1917 Clinic. His research focuses on the influence of socio-behavioral and contextual factors across the HIV care continuum.
DEVELOPING TECHNOLOGY-BASED HIV PREVENTION FOR YOUNG POPULATIONS
Michele Ybarra, MPH, PhD
Center for Innovative Public Health Research (CiPHR)
Michele Ybarra M.P.H., Ph.D. is the President and Research Director of the Center for Innovative Public Health Research (CiPHR),a non-profit research organization in southern California. Her work focuses on how technology is affecting the health and well being of youth, as well as how we can use technology to promote healthy behaviors.
NETWORK INTERVENTIONS FOR HIV ELIMINATION IN THE US
John Schneider, MD, MPH
Departments of Medicine and Public Health Sciences, University of Chicago
Dr. Schneider is an infectious disease specialist and network epidemiologist in the Departments of Medicine and Public Health Sciences at the University of Chicago. He is also Director of the University of Chicago Center for HIV Elimination. His NIH- and CDC-funded research focuses on how social networks can be leveraged to improve the health of populations at risk for HIV and other sexually transmitted infections in resource restricted settings.
BUILDING THE NEXT STAGE OF IMPLEMENTATION SCIENCE TO SUPPORT HIV PREVENTION
C. Hendricks Brown, PhD
Center for Prevention Implementation Methodology for Drug Abuse and HIV, Northwestern University
Dr. C. Hendricks Brown is a Professor of Psychiatry and Behavioral Sciences at the Northwestern University Feinberg School of Medicine. He directs the NIDA-funded Center for Prevention Implementation Methodology (Ce-PIM) for Drug Abuse and HIV. He has received support from the NIDA, NIMH, and CDC to develop statistical methods for the design and analysis of preventive and early intervention field trials.
TOP 10 GAME-CHANGERS IN HIV MEDICINE
David Wohl, MD
Division of Infectious Diseases,
University of North Carolina at Chapel Hill
Dr. David Wohl is a Professor of Medicine in the Division of Infectious Diseases at University of North Carolina (UNC). He is Site Leader of the UNC AIDS Clinical Trials Unit at Chapel Hill, Director of the North Carolina AETC, and Co-Director of HIV services for the North Carolina State prison system.
Dr. Wohl's research aims to optimize the treatment and prevention of HIV infection, particularly for vulnerable populations, such as the incarcerated.
HEART TO HEART: A CULTURALLY APPROPRIATE EFFICACIOUS INTERVENTION FOR PLWH OF COLOR WHO HAVE DELAYED, DECLINED, OR DISCONTINUED ART
Marya Viorst Gwadz, Ph.D.
Center for Drug Use and HIV Research,
NYU College of Nursing
Dr. Gwadz is a licensed clinical psychologist, and the Director of the Transdisciplinary Research Methods Core in CDUHR. Her research focuses on identifying approaches to increase health equity among African American/Black and Hispanic populations. She has been leading social and behavioral intervention trials for over two decades, with an emphasis on studies to address HIV and drug use-related health disparities in urban populations of color, and among women.
INTERSECTING EPIDEMICS: EVIDENCED-BASED APPROACHES FOR TREATING DEPRESSION AND HIV/AIDS
Steven A. Safren, PhD
Department of Psychology, University of Miami
Dr. Steven Safren, is a Professsor of Psychology at the University of Miami who conducts domestic and international research on behavioral aspects of HIV prevention and treatment.
Dr. Safren has particular expertise on addressing mental health problems such as depression in psychosocial interventions for adherence to antiretroviral therapy.
PRE-EXPOSURE PROPHYLAXIS IN WOMEN: CHALLENGES AND PROSPECTS
Salim Abdool Karim, M.B.Ch.B., Ph.D., D.Sc..
Center for AIDS Programme of Research in South Africa (CAPRISA) and University of Kwazulu Natal, South Africa
Dr. Abdool Karim is a South African clinical infectious diseases epidemiologist who is widely recognised for his ground-breaking scientific contributions in HIV prevention and treatment. He is Director of the Centre for the AIDS Program of Research in South Africa (CAPRISA) and Professor of Clinical Epidemiology at the Mailman School of Public Health at Columbia University.
2016 Grand Rounds
December 1: MOVING BEYOND TRUVADA: THE NEXT GENERATION OF BIOMEDICAL HIV PREVENTION
Raphael Landovitz, MD, MSc
University of California, Los Angeles
November 17: BEYOND RESERVOIRS AND LATENCY: SOCIAL, BEHAVIORAL AND ETHICAL CONSIDERATIONS IN HIV CURE RESEARCH
Judith Auerbach, PhD
University of California, San Francisco
November 10: CONTEXT MATTERS: ADDRESSING COMMUNITY SOCIAL ENVIRONMENTS TO IMPROVE HIV PREVENTION AND CARE IN SUB-SAHARAN AFRICA
Sheri Lippman, PhD
Center for AIDS Prevention Studies, University of California, San Francisco
October 27: THE CONTINUUM OF CARE AMONG MSM IN CHINA: FINAL RESULTS FROM THE CHINA MP3 STUDY
Sten Vermund, MD, PhD
Vanderbilt University Medical Center
October 13: PSYCHOLOGICAL AND STRUCTURAL FACTORS RELATED TO HEALTH PROMOTION AMONG HIV-INFECTED YOUTH
Patrick Wilson, PhD
Columbia University Mailman School of Public Health
June 16: MODELING DYNAMIC POLICY CHANGES IN NEW YORK STATE: THE HIV TESTING LAW AND BLUEPRINT TO END AIDS
Erika Martin, PhD, MPH
Rockefeller Institute of Government and University at Albany, SUNY
May 26: RANDOMIZED TRIAL OF PATIENT NAVIGATION AND CONTINGENCY MANAGEMENT FOR HOSPITALIZED HIV-POSITIVE SUBSTANCE USERS
Lisa Metsch, PhD
Department of Sociomedical Sciences, Columbia University Mailman School of Public Health
May 12: WOMEN, HIV, AND AGING
Gina Wingood, ScD, MPH
Lerner Center for Public Health Promotion, Columbia University Mailman School of Public Health
April 14: NO TIME TO LOSE: EFFECTS OF EARLY TREATMENT ON THE BRAIN AND THE BODY IN CHILDREN AND ADULTS
Jintanat Ananworanich, MD, PhD
US Military HIV Research Program and SEARCH: Thai Red Cross AIDS Research Center
March 31: HIV AND THE BRAIN IN 2016: WHAT WE KNOW AND WHAT WE NEED TO LEARN
Serena S. Spudich, MD
Division of Neurological Infections and Global Neurology, Yale University
Kenneth Mayer, MD
Beth Israel Deaconess Medical Center, Harvard Medical School, The Fenway Institute
February 18: COMPARISON OF ADHERENCE METHODOLOGIES IN AN ART-NAÏVE COHORT: WHICH BEST PREDICTS VIROLOGICAL AND RESISTANCE OUTCOMES?
Catherine Orrell, MBChB, MMed
Desmond Tutu HIV Foundation, University of Cape Town, South Africa
Susan J. Little, MD
Department of Medicine, University of California, San Diego